Design and analyze an in silico cohort for your next market analysis, R&D, or real world evidence (RWE) project from our database of 3M+ de-identified EMRs. Nashville Biosciences guides your scientists through the process of curating and analyzing custom controlled cohorts. Applications include synthetic control arms for clinical trials, natural history studies, trial recruitment optimization and comparative effectiveness analyses.
Molecular Data Generation
Overlay BioVU®’s existing 2M+ marker genotype data onto your in silico cohort, or generate new molecular data from DNA, Blood, plasma and other research-grade biospecimens collected through BioVU®. Nashville Biosciences can facilitate whole genome/exome sequencing, genotyping, and other omics analyses, as well as a range of bioinformatics services, providing custom R&D pipelines for rich molecular analyses. Example applications include variant, target and biomarker identification and validation.
Leverage decades of real world clinical history and linked genotype data from BioVU® to uncover genetic associations between drug targets and disease phenotypes and identify novel therapeutic indications and adverse event risks. Nashville Biosciences leverages the power of pheWAS™ to help pharma and biotech companies with pre-clinical planning, portfolio prioritization, drug rescue and repositioning, and lifecycle extension.